Director/PDMR Shareholding | 16-Apr-2024 | 14:04 | RNS |
Exercise of Share Options and Total Voting Rights | 15-Apr-2024 | 17:56 | RNS |
Exercise of Share Options and Total Voting Rights | 19-Mar-2024 | 09:25 | RNS |
Exercise of Share Options and Total Voting Rights | 27-Feb-2024 | 07:00 | RNS |
Half-year Report | 26-Feb-2024 | 07:01 | RNS |
UK and EU regulatory approval update | 26-Feb-2024 | 07:00 | RNS |
Exercise of Share Options and Total Voting Rights | 08-Feb-2024 | 07:00 | RNS |
Notice of Interim Results | 01-Feb-2024 | 07:00 | RNS |
Exercise of Share Options and Total Voting Rights | 25-Jan-2024 | 07:00 | RNS |
Canadian regulatory approval for Tristel ULT | 23-Jan-2024 | 07:00 | RNS |
Director/PDMR Shareholding | 10-Jan-2024 | 14:27 | RNS |
Result of AGM | 19-Dec-2023 | 12:02 | RNS |
AGM Statement | 19-Dec-2023 | 07:00 | RNS |
Exercise of Share Options and Total Voting Rights | 07-Dec-2023 | 14:05 | RNS |
Exercise of Share Options and Total Voting Rights | 01-Dec-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 480.00p |
Change Today | 15.00p |
% Change | 3.23 % |
52 Week High | 485.00 |
52 Week Low | 327.50 |
Volume | 33,518 |
Shares Issued | 47.52m |
Market Cap | £228.12m |
RiskGrade | 180 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 1 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 21-Mar-24 | 23-Nov-23 |
Paid | 12-Apr-24 | 22-Dec-23 |
Amount | 5.24p | 7.88p |
Time | Volume / Share Price |
16:35 | 1 @ 480.00p |
16:35 | 2 @ 460.00p |
16:35 | 18 @ 480.00p |
16:35 | 7 @ 480.00p |
16:35 | 7 @ 480.00p |
CEO | Paul Christopher Swinney |
Finance Director | Elizabeth Dixon |
You are here: research